Abstract A41: Use of patient-derived tumor xenografts (PDX) for discovery and development of an anti-Notch2/3 monoclonal antibody targeting cancer stem cells

Author(s):  
Marcus M. Fischer ◽  
Wan-Ching Yen ◽  
Fumiko Axelrod ◽  
Christopher Bond ◽  
Jennifer Cain ◽  
...  
2015 ◽  
Author(s):  
Jeff Holderness ◽  
Amy Turner ◽  
Sam dolezal ◽  
Steve Wolpe ◽  
Michael Pierce ◽  
...  

Blood ◽  
2014 ◽  
Vol 123 (8) ◽  
pp. 1218-1228 ◽  
Author(s):  
Eva Nievergall ◽  
Hayley S. Ramshaw ◽  
Agnes S. M. Yong ◽  
Mark Biondo ◽  
Samantha J. Busfield ◽  
...  

Key Points IL-3 receptor α (CD123) expression is elevated in CML progenitor and stem cells compared with healthy donors. CD123 monoclonal antibody targeting represents a novel, potentially clinically relevant approach to deplete CML progenitor and stem cells.


2016 ◽  
Vol 61 ◽  
pp. S194
Author(s):  
L. Atapattu ◽  
N. Saha ◽  
C. Chheang ◽  
M. Vail ◽  
M. Eissman ◽  
...  

Leukemia ◽  
2012 ◽  
Vol 26 (9) ◽  
pp. 2124-2134 ◽  
Author(s):  
A Ikegame ◽  
S Ozaki ◽  
D Tsuji ◽  
T Harada ◽  
S Fujii ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document